Chanil Chung

Bio-Medical Science (South Korea)

Papers

1

Total Citations

40

H-Index

1

About

Chanil Chung is a pioneering figure in microfluidics and lab-on-a-chip technologies, with a core focus on developing high-throughput screening tools for pharmaceutical and biomedical applications. His most influential work, the 2004 paper "Serial dilution microchip for cytotoxicity test," has garnered 40 citations and addresses a critical bottleneck in drug discovery: the need for rapid, miniaturized cytotoxicity assays. By designing a microchip capable of automated serial dilution, Chung enabled parallel testing of multiple compound concentrations on a single platform, dramatically reducing reagent use and processing time. This innovation directly tackled the challenges posed by high-throughput screening (HTS) in the pharmaceutical industry, where sample numbers have surged. His contributions have advanced the integration of microfluidics into routine toxicological assessment, offering a scalable solution for compound safety evaluation. Chung’s work stands as a foundational step toward more efficient, cost-effective drug development pipelines, influencing subsequent research in microchip-based bioassays and personalized medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Serial dilution microchip for cytotoxicity test
40 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Bio-Medical Science (South Korea)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago